Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phage Cocktail Therapy for MDR Gram-Negative VAP
NCT07202234Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Nov 2025
- Primary completion
- May 2028
- Modality
- Microbiome Therapeutics
01
Overview
Randomised trial of bacteriophage cocktail in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Clinical response rate at 10 days. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
bacteriophage cocktail
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT07202234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07202234.